ZA201101565B - Tablet manufacturing method - Google Patents

Tablet manufacturing method

Info

Publication number
ZA201101565B
ZA201101565B ZA2011/01565A ZA201101565A ZA201101565B ZA 201101565 B ZA201101565 B ZA 201101565B ZA 2011/01565 A ZA2011/01565 A ZA 2011/01565A ZA 201101565 A ZA201101565 A ZA 201101565A ZA 201101565 B ZA201101565 B ZA 201101565B
Authority
ZA
South Africa
Prior art keywords
tablet manufacturing
tablet
manufacturing
Prior art date
Application number
ZA2011/01565A
Inventor
Alawi Fadil Al
Karthigeyan Nanjan
Wayne Frederick Leech
Original Assignee
Bomac Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bomac Research Ltd filed Critical Bomac Research Ltd
Publication of ZA201101565B publication Critical patent/ZA201101565B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2011/01565A 2008-07-29 2011-02-28 Tablet manufacturing method ZA201101565B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NZ2008/000190 WO2010014015A1 (en) 2008-07-29 2008-07-29 Tablet manufacturing method

Publications (1)

Publication Number Publication Date
ZA201101565B true ZA201101565B (en) 2015-10-28

Family

ID=41610570

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/01565A ZA201101565B (en) 2008-07-29 2011-02-28 Tablet manufacturing method

Country Status (4)

Country Link
AU (1) AU2008360070B2 (en)
BR (1) BRPI0822980A2 (en)
WO (1) WO2010014015A1 (en)
ZA (1) ZA201101565B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103919745B (en) * 2014-05-08 2017-01-11 成都乾坤动物药业有限公司 Coloring formula and technology of veterinary use benzimidazole vermifuge
WO2018038623A1 (en) * 2016-08-23 2018-03-01 Donaghys Limited Improvements in parasite treatments
CN111067875B (en) * 2020-01-16 2021-11-30 兰州大学 Albendazole liquid-solid compressed tablet and preparation method thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000074489A1 (en) * 1999-06-04 2000-12-14 Nufarm Limited Stable biocidal compositions
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
US7582612B2 (en) * 2004-03-12 2009-09-01 Hartz Mountain Corporation Multi-action anthelmintic formulations
WO2005099692A1 (en) * 2004-04-07 2005-10-27 Intervet International B.V Efficacious composition of a benzimidazole, an avermectin and praziquantel and related methods of use
NZ552293A (en) * 2006-12-21 2009-03-31 Bomac Research Ltd Tablet formulation comprising a macrocyclic lactone and a levamisole compound having anthelmintic activity
NZ552290A (en) * 2006-12-21 2009-05-31 Bomac Research Ltd Tablet fomulation

Also Published As

Publication number Publication date
AU2008360070A1 (en) 2010-02-04
AU2008360070B2 (en) 2015-04-30
BRPI0822980A2 (en) 2015-06-23
WO2010014015A1 (en) 2010-02-04

Similar Documents

Publication Publication Date Title
PL2373494T3 (en) Methods for manufacturing panels
EP2330605A4 (en) Capacitor manufacturing method
ZA201007720B (en) Production method
HK1141864A1 (en) Display manufacturing method
GB0818093D0 (en) Method
GB0803107D0 (en) Method
GB0810418D0 (en) Method
GB0807409D0 (en) Method
GB0815428D0 (en) Method
GB0813599D0 (en) Method
GB0807410D0 (en) Method
GB0804981D0 (en) Method
GB0804690D0 (en) Method
EP2261262A4 (en) Method for manufacturing polyuronate
EP2239093A4 (en) Production facility
GB0809404D0 (en) Method
EP2543502A4 (en) Tablet manufacturing method
EP2340161A4 (en) Manufacturing process
EP2321435A4 (en) Recarburisation method
EP2371796A4 (en) Method for manufacturing glycerin
GB0812559D0 (en) Method
GB0805862D0 (en) Method
GB0813494D0 (en) Method
GB2481174B (en) Manufacturing process
GB0812102D0 (en) Method